ABBONANTE, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 1.975
AS - Asia 1.440
EU - Europa 1.258
SA - Sud America 194
AF - Africa 67
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.937
Nazione #
US - Stati Uniti d'America 1.924
CN - Cina 673
IE - Irlanda 343
SG - Singapore 291
DE - Germania 180
VN - Vietnam 168
HK - Hong Kong 161
RU - Federazione Russa 161
IT - Italia 156
BR - Brasile 138
FI - Finlandia 121
SE - Svezia 74
GB - Regno Unito 66
FR - Francia 57
ZA - Sudafrica 38
IN - India 33
CA - Canada 29
AR - Argentina 25
PL - Polonia 23
UA - Ucraina 20
BD - Bangladesh 19
JP - Giappone 18
TR - Turchia 12
CO - Colombia 11
CZ - Repubblica Ceca 11
MX - Messico 11
NL - Olanda 10
ES - Italia 9
MA - Marocco 9
EC - Ecuador 8
IQ - Iraq 8
PK - Pakistan 7
AT - Austria 6
PH - Filippine 6
SA - Arabia Saudita 6
KE - Kenya 5
UZ - Uzbekistan 5
EG - Egitto 4
MU - Mauritius 4
MY - Malesia 4
BO - Bolivia 3
CR - Costa Rica 3
ID - Indonesia 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
PE - Perù 3
RO - Romania 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
HR - Croazia 2
KH - Cambogia 2
KR - Corea 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
LY - Libia 1
NO - Norvegia 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
YE - Yemen 1
Totale 4.937
Città #
Dublin 343
Chandler 254
San Jose 226
Ashburn 225
Beijing 179
Dallas 173
Hong Kong 154
Singapore 152
Nanjing 117
Council Bluffs 77
Helsinki 73
Los Angeles 64
Pavia 63
Jacksonville 55
Munich 49
Ho Chi Minh City 47
Hanoi 46
Boardman 45
New York 45
Lauterbourg 40
Nanchang 40
Shenyang 40
Lawrence 38
Princeton 38
Medford 37
Johannesburg 36
Changsha 29
Tianjin 27
Wilmington 26
Shanghai 25
Hebei 24
Turku 24
São Paulo 23
Jiaxing 21
Da Nang 20
Redondo Beach 20
Santa Clara 20
Columbus 18
Tokyo 17
Warsaw 17
Hangzhou 16
Denver 15
Moscow 15
Atlanta 13
Orem 13
Toronto 13
Augusta 12
The Dalles 12
Ann Arbor 11
San Francisco 11
Washington 11
Brooklyn 10
Buffalo 10
Frankfurt am Main 10
Montreal 10
Boston 9
Falkenstein 9
Manchester 9
Phoenix 9
Woodbridge 9
Chicago 8
Amsterdam 7
Chennai 7
Brno 6
Gallarate 6
Haiphong 6
Hanover 6
London 6
Mexico City 6
Milan 6
Poplar 6
Seattle 6
Stockholm 6
Ankara 5
Baghdad 5
Buenos Aires 5
Leawood 5
Nairobi 5
Quito 5
Secaucus 5
Belo Horizonte 4
Casablanca 4
Dhaka 4
Guangzhou 4
Houston 4
Norwalk 4
Olomouc 4
Riyadh 4
Santo André 4
Tashkent 4
Vienna 4
Amman 3
Ardabil 3
Brasília 3
Casorate Primo 3
Elk Grove Village 3
Fairfield 3
Fiesole 3
Hải Dương 3
Jinan 3
Totale 3.382
Nome #
Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application 207
Adhesion to different collagens modulates megakaryocyte development 188
Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets 156
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms 154
Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells 152
Extracellular matrix nano-mechanics determines megakaryocyte function 142
Effect of Interferon-γ on the Basal and the TNF α-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement or the BRAF V600e Mutation 136
Definition of the Native and Denatured Type II Collagen Binding Site for Fibronectin Using a Recombinant Collagen System 135
Abnormal regulation of intracellular Ca2+ in human megakaryocytes contributes to the pathophysiology of CALR-mutant myeloproliferative neoplasms. 135
JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF). 132
Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity 131
Thrombopoietin/TGF-β1 loop regulates megakaryocyte extracellular matrix component synthesis 130
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 129
Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis. 128
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin 128
Discoidin Domain Receptor 1 is a novel modulator of megakaryocyte-collagen interactions 126
A newly identified platelet and megakaryocyte lysyl oxidase adhesion to collagen axis in human primary myelofibrosis 126
Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy 125
The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control 125
A new path to platelet production through matrix sensing 123
EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis 120
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 119
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 118
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms 117
Ablation of Collagen VI leads to the release of platelets with altered function 115
DDR1 activation determines megakaryocyte migration on type I collagen. 114
EDA Fibronectin-TLR4 Axis Sustains Megakaryocyte Expansion and Inflammation during Bone Marrow Fibrosis Progression. 111
Hyaluronan based hydrogels provide an improved model to study megakaryocyte-matrix interactions 108
Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis 102
Gel-free sample preparation for the nanoscale LC-MS/MS analysis and identification of low-nanogram protein samples 101
Recombinant collagen engineered to bind to discoidin domain receptor functions as a receptor inhibitor 101
Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation 100
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration 95
Bone marrow microenvironment of MPN cells 90
Three-dimensional tissue models for studying ex vivo megakaryocytopoiesis and platelet production 87
iPSC diversity: A key for better use and improved targeting 81
Mechanisms of platelet release: in vivo studies and in vitro modeling 73
Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis 71
Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver 68
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis 66
Increased B4GALT1 expression is associated with platelet surface galactosylation and thrombopoietin plasma levels in MPNs 65
Ablation of collagen VI leads to the release of platelets with altered function 62
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis 61
Expression and functional characterization of the large‐conductance calcium and voltage‐activated potassium channel Kca1.1 in megakaryocytes and platelets 49
Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis 43
null 7
Dose-dependent effects of eltrombopag iron chelation on platelet formation 3
Circulating Levels of PF4/CXCL4 in Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: A New Potential Prognostic Factor for Disease Progression 2
Illustrated capsules from the Advanced Course in Platelet Research 1
Totale 5.058
Categoria #
all - tutte 20.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022262 4 0 5 49 3 1 2 8 11 45 28 106
2022/2023727 81 75 7 54 55 54 2 34 335 4 13 13
2023/2024357 40 57 12 9 31 137 3 35 2 7 10 14
2024/2025887 24 50 21 14 17 51 40 48 234 43 126 219
2025/20261.979 147 116 218 198 235 90 400 102 201 132 88 52
Totale 5.058